The HIV-Positive Traveler

American Journal of Medicine

Volumn 120, Issue 7, 2007, Pages 574-580

  Bhadelia, Nahid ^a   Klotman, Mary ^a   Caplivski, Daniel ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Human immunodeficiency virus; International travel; Malaria; Travel restrictions; Traveler's diarrhea; Vaccination

Indexed keywords

AMPRENAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; ATOVAQUONE PLUS PROGUANIL; CLARITHROMYCIN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DOXYCYCLINE; EFAVIRENZ; ERYTHROMYCIN; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INDINAVIR; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; LOPINAVIR; MACROLIDE; MEFLOQUINE; MENINGOCOCCUS VACCINE; NELFINAVIR; NEVIRAPINE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RABIES VACCINE; RIFAXIMIN; RITONAVIR; TYPHOID VACCINE; ZIDOVUDINE;

ABDOMINAL PAIN; ANAPHYLAXIS; ANOREXIA; CANDIDIASIS; DELAYED HYPERSENSITIVITY; DIPHTHERIA; DIZZINESS; EMPORIATRICS; EPIDEMIC ENCEPHALITIS; GASTROINTESTINAL SYMPTOM; HEADACHE; HEPATITIS A; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; INFLUENZA; INSOMNIA; MALARIA; MENTAL DISEASE; NAUSEA; NIGHTMARE; PATIENT ASSESSMENT; PATIENT COUNSELING; PHOTOSENSITIVITY; POLIOMYELITIS; PRIORITY JOURNAL; RABIES; RASH; REVIEW; SEXUALLY TRANSMITTED DISEASE; SINUS ARRHYTHMIA; SLEEP DISORDER; STREPTOCOCCUS INFECTION; TETANUS; TRAVELLER DIARRHEA; TYPHOID FEVER; VACCINATION; VOMITING; YELLOW FEVER;

ANTI-HIV AGENTS; COMMUNICABLE DISEASE CONTROL; DIARRHEA; GOVERNMENT REGULATION; HIV INFECTIONS; HUMANS; INTERNATIONALITY; MALARIA; SEXUALLY TRANSMITTED DISEASES; TRAVEL; VACCINATION; VACCINES;

EID: 34250839433     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2007.02.018     Document Type: Review

References (45)

1. Castelli F., and Patroni A. The human immunodeficiency virus infected traveler. Clin Infect Dis 31 (2000) 1403-1408
2. Hill D.R., Ericsson C.D., Pearson R.D., et al., Infectious Diseases Society of America. The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43 (2006) 1499-1539
3. Tatteevin P., Depatureaux A., Chapplain J., et al. Yellow fever vaccine is safe and effective in HIV-infected patients. AIDS 18 (2004) 825-827
4. Adult Sullivan P.S., Hanson D.L., Dworkin M.S., Jones J.L., Ward J.W., and Adolescent Spectrum of HIV Disease Investigators. Effect of influenza vaccination on disease progression among HIV-infected persons. AIDS 14 (2000) 2781-2785
5. World Health Organization. Yellow Fever, Revised 2001. Fact Sheet No. 100 (2006). http://www.who.int/mediacentre/factsheets/fs100/en/ Available at: http://www.who.int/mediacentre/factsheets/fs100/en/. Accessed November 30
6. Goujon C., Tohr M., Feuilleie V., et al. Good tolerance and efficacy of yellow fever vaccine among carriers of human immunodeficiency virus. J Travel Med 2 (1995) 145
7. Department of Health and Human Services, Centers for Disease Control. Meningococcal vaccines: what you need to know. Available at: http://www.cdc.gov/nip/publications/vis/vis-mening.pdf.
8. Prevention (CDC). Centers for Disease Control and Update: Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine-United States, June 2005-September 2006. MMWR Morb Mortal Wkly Rep 55 (2006) 1120-1124
9. Birx D.L., Rhoads J.L., Wright J.C., et al. Immunologic parameters in early-stage HIV-seropositive subjects associated with vaccine responsiveness. J Acquir Immune Defic Syndr 4 (1991) 188-196
10. Mueller J.E., Borrow R., and Gessner B.D. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines. Exp Rev Vaccines 5 (2006) 319-336
11. Laurence J.C. Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus. Am J Med 118 Suppl 10A (2005) 75S-83S
12. Connor B.A. Hepatitis A vaccine in the last-minute traveler. Am J Med 118 Suppl 10A (2005) 58S-62S
13. Fonseca M.O., Pang L.W., de Paula Cavalheiro N., et al. Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose. Vaccine 23 (2005) 2902-2908
14. Keitel W.A., Bond N.L., Zahradnik J.M., et al. Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines. Vaccine 12 (1994) 195-199
15. Kroon F.P., van Dissel J.T., Ravensbergen E., et al. Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi). Vaccine 17 (1999) 2941-2945
16. Department of Health and Human Services, Centers for Disease Control. Japanese encephalitis vaccine: what you need to know. Available at: http://www.cdc.gov/nip/publications/vis/vis-je.pdf.
17. Rojanasuphot S., Shaffer N., Chotpitayasunondh T., et al. Response to JE vaccine among HIV-infected children, Bangkok, Thailand. Southeast Asian J Trop Med Public Health 29 (1998) 443-450
18. Pancharoen C., Thisyakorn U., Tantawichien T., et al. Failure of pre- and postexposure rabies vaccinations in a child infected with HIV. Scand J Infect Dis 33 (2001) 390-391
19. Centers for Disease Control (CDC). Progress toward poliomyelitis eradication-India, January 2005-June 2006. MMWR Morb Mortal Wkly Rep 55 (2006) 772-776
20. French N., Nakiyingi J., Carpenter L.M., et al. 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet 355 (2000) 2106-2111
21. Miiro G., Kayhty H., Watera C., et al. Conjugate pneumococcal vaccine in HIV-infected Ugandans and the effect of past receipt of polysaccharide vaccine. J Infect Dis 192 (2005) 1801-1805
22. Rieder H.L. Risk of travel-associated tuberculosis. Clin Infect Dis 33 (2001) 1393-1396
23. Hesseling A.C., Rabie H., Marais B.J., et al. Bacille Calmette-Guerin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis 42 (2006) 548-558
24. Centers for Disease Control and Prevention (CDC). Chapter 4: Prevention of specific diseases-Malaria. In: Kozarsky P.E., Arguin P.M., and Navin A.W. (Eds). The Yellow Book-Health Information for International Travel, 2005-2006 (2006). http://www.cdc.gov/travel/yb/ Available at: http://www.cdc.gov/travel/yb/. Accessed November 1
25. Matteelli A., Casalini C., Bussi G., et al. Imported malaria in an HIV-positive traveler: a case report with a fatal outcome. J Travel Med 12 (2005) 222-224
26. Cohen C., Karstaedt A., Frean J., et al. Increased prevalence of severe malaria in HIV-infected adults in South Africa. Clin Infect Dis 41 (2005) 1631-1637
27. Kamya M.R., Gasasira A.F., Yeka A., et al. Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study. J Infect Dis 193 (2006) 9-15
28. Hoffman I.F., Jere C.S., Taylor T.E., et al. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS 13 (1999) 487-494
29. Mermin J., Lule J.R., and Ekwaru J.P. Association between malaria and CD4 cell count decline among persons with HIV. J Acquir Immune Defic Syndr 41 (2006) 129-130
30. Salit I.E., Sano M., Boggild A.K., and Kain K.C. Travel patterns and risk behaviour of HIV-positive people travelling internationally. Can Med Assoc J 172 (2005) 884-888
31. Taylor W.R., and White N.J. Antimalarial drug toxicity: a review. Drug Saf 27 (2004) 25-61
32. Cavassini M.L., D'Acremont V., Furrer H., et al. Pharmacotherapy, vaccines and malaria advice for HIV-infected travelers. Exp Opin Pharmacother 6 (2005) 891-913
33. Khoo S., Back D., and Winstanley P. The potential for interactions between antimalarial and antiretroviral drugs. AIDS 19 (2005) 995-1005
34. World Health Organization (WHO). 2006 Guidelines for the Treatment of Malaria (WHO/HTM/MAL/2006.1108) (2006). http://www.who.int/malaria/docs/TreatmentGuidelines2006.pdf Available at: http://www.who.int/malaria/docs/TreatmentGuidelines2006.pdf. Accessed November 1
35. Wright M.S., and Collins P.A. Waterborne transmission of Cryptosporidium, Cyclospora and Giardia. Clin Lab Sci 10 (1997) 287-290
36. Tjaniadi P., Lesmana M., Subekti D., et al. Antimicrobial resistance of bacterial pathogens associated with diarrheal patients in Indonesia. Am J Trop Med Hyg 68 (2003) 666-670
37. Adachi J.A., Ericsson C.D., Jean Z.D., et al. Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. Clin Infect Dis 37 (2003) 1165-1171
38. Taylor D.N., Bourgeois A.L., Ericsson C.D., et al. A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea. Am J Trop Med Hyg 74 (2006) 1060-1066
39. Ilnyckyj A., Balachandra B., Elliott L., et al. Post-traveler's diarrhea irritable bowel syndrome: a prospective study. Am J Gastroenterol 98 (2003) 596-599
40. Ward B.J., and Plourde P. Travel and sexually transmitted infections. J Travel Med 13 (2006) 300-317
41. Visco-Comandini U., and Balotta C. Genotypic resistance tests for the management of the HIV-infected patient with non-B viral isolates. Scand J Infect Dis Suppl 35 (2003) 75-78
42. Deutsche AIDS-Hilfe; Wiessner P, Lemmen K, eds. Quick Reference-Travel and Residence Regulations for People with HIV and AIDS. Available at: www.aidsnet.ch/linkto/immigration. Accessed November 1, 2006.
43. United States Department of State, and Bureau of Consular Affairs. Human Immunodeficiency Virus (HIV) Testing Requirements for Entry into Foreign Countries (2006). http://travel.state.gov/travel/tips/brochures/brochures_1230.html Available at: http://travel.state.gov/travel/tips/brochures/brochures_1230.html. Accessed November 1, 2006
44. Canadian HIV/AIDS Legal Network. HIV/AIDS-related travel restrictions-UNAIDS/International Organization of Migration statement and revision of International Health Regulations. Can HIV/AIDS Policy Law Rev 9 (2004) 37
45. Adams B. HIV and travel: the world may not be your oyster when you roam openly as HIV-positive. The Advocate, Oct 26, 2004. Available at: http://www.advocate.com. Accessed November 1, 2006.